skip to navigation skip to content

Healthcare Convergence Initiative

Delivering Precision Population Health Solutions to end fragmentation in healthcare

Our mission: a Global Centre for Healthcare Convergence

The Global Centre for Healthcare Convergence (GCHC) will optimise health outcomes for specific populations at risk escalation point by introducing Precision Population Health Solutions™. This scalable, evidence-based business model will bring an end to harmful health system fragmentation for these populations, by aligning interests of digital, pharmaceutical, diagnostic, data technologies with payments, health provider workforce, local incentives and government stakeholders to achieve better patient outcomes.

As a new global research institute, GCHC will conduct cutting edge research that informs governments, regulators and payors on the implications of precision population health, whilst it also incubates solutions, as exemplars, to address specific tractable population health challenges.

The challenge

Today, healthcare systems face considerable fragmentation in terms of workforce, incentives and technology.  Population outcomes depend upon the careful coordination of all three, yet they are each contracted separately leading to uncontrollable variability in outcomes. This is bad for all concerned. It is bad for industries that rely upon proving superiority of outcomes to gain purchase, it is bad for providers of care that rely upon operational clarity to manage sustainable revenue and cost, and most importantly, it is bad for patients who want good, consistent healthcare. For payors and insurers it makes identifying and managing risk for populations problematic. And when innovative technologies become available it means whilst these should, in theory, reap benefits, in practice a new tool added to an already chaotic system can create additional confusion which can perversely lead to poorer outcomes whilst increasing cost. For governments, the unwarranted variability in care leads to inequalities further exacerbated by social determinants, with enormous issues of cost sustainability of healthcare and access. Fragmentation is a root cause for many social challenges.

A joint global strategic initiative between Cambridge Judge Business School and Excite Ventures.

Logo: Global Centre for Healthcare Convergence.
Logo: Excite Ventures.

The vision – precision population health solutions

To remain relevant, healthcare of the future needs to include new entities that utilise convergent business models that integrate technologies, workforce, and incentives in a way that they can be delivered and scaled world-wide. We call these convergent business models Precision Population Health Solutions. They must be population specific, predictably effective, and robustly replicable and hence scalable. We expect these businesses to become a ‘mark of standard’ for payors in the future. In the same way that integrators such as Apple and Dell, brought together the fragmented computer components industry, creating end-to-end systems that could make computing low cost and ubiquitous, the same opportunity is available now in healthcare. With the advent of AI, personalised therapies, miniature sensors, and diagnostic tools, mobile telecommunications, never before has there been such an opportunity to address population health, but to do this requires new business models and scalability.

In collaboration between Cambridge Judge Business School at the University of Cambridge, Excite Ventures, together with select leading US, European and Asian academic groups we will establish the Global Centre for Healthcare Convergence as the premier global research institute to re-shape healthcare systems globally. This ‘think-do tank’ will end fragmentation for populations at risk escalation point, capping risk, through convergent business models that integrate the end-to-end solutions required to reproduce the best possible population outcomes in a highly scalable manner (based on ‘what works’ already). This collaboration aims not only to modify policy in health systems around the world based on systematic research that helps payors, governments, and regulators to understand the implications of convergence on the sector but will also incubate and scale new ventures that exemplify it.

Initiative leads

Anoop Maini

Fellow in Health Management

CEO, Excite Ventures

Stefan Scholtes

Dennis Gillings Professor of Health Management

PhD (Karlsruhe University)

Contact us

For more information, contact Anoop Maini.

[email protected]